Kazia Therapeutics (KZIA) Total Current Liabilities (2017 - 2025)
Kazia Therapeutics' Total Current Liabilities history spans 6 years, with the latest figure at $9.0 million for Q2 2025.
- For Q2 2025, Total Current Liabilities fell 47.06% year-over-year to $9.0 million; the TTM value through Jun 2025 reached $9.0 million, down 47.06%, while the annual FY2025 figure was $9.0 million, 47.06% down from the prior year.
- Total Current Liabilities reached $9.0 million in Q2 2025 per KZIA's latest filing, down from $17.0 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $17.0 million in Q2 2024 to a low of $4.8 million in Q2 2022.
- Average Total Current Liabilities over 4 years is $9.0 million, with a median of $7.0 million recorded in 2023.
- Peak YoY movement for Total Current Liabilities: skyrocketed 236.24% in 2024, then crashed 47.06% in 2025.
- A 4-year view of Total Current Liabilities shows it stood at $4.8 million in 2022, then rose by 4.92% to $5.1 million in 2023, then surged by 236.24% to $17.0 million in 2024, then plummeted by 47.06% to $9.0 million in 2025.
- Per Business Quant, the three most recent readings for KZIA's Total Current Liabilities are $9.0 million (Q2 2025), $17.0 million (Q2 2024), and $5.1 million (Q2 2023).